Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity

Outcomes after Laser versus Combined Laser and Bevacizumab Treatment for Type 1 Retinopathy of Prematurity in Zone I.

PURPOSE To investigate the anatomical and refractive outcomes in patients with Type 1 retinopathy of prematurity in Zone I. METHODS The medical records of 101 eyes of 51 consecutive infants with Type 1 retinopathy of prematurity in Zone I were analyzed. Infants were treated by conventional laser photocoagulation (Group I), combined intravitreal bevacizumab injection and Zone I sparing laser (...

Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser.

PURPOSE To compare structural outcomes, visual function, refraction, and frequency of follow-up for infants with type 1 retinopathy of prematurity in zone I or zone II posterior treated with intravitreal bevacizumab (IVB) versus laser. METHODS The medical records of infants treated with IVB or laser photocoagulation at our institution from January 2009 to May 2013 were retrospectively reviewe...

Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.

PURPOSE To compare the structural outcome at 9 months of eyes treated with intravitreal injection of bevacizumab with fellow eyes treated with conventional laser photoablation in zone I type 1 retinopathy of prematurity (ROP). DESIGN Single randomized controlled trial. PARTICIPANTS All inborn babies with type 1 zone I ROP at a single institution were included in the study. One eye was rando...

Transpupillary Diode Laser Retinal Photocoagulation for the Treatment of Retinopathy of Prematurity: Experience in Southern Iran

Bevacizumab for retinopathy of prematurity.